Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes.
Author
Jentzer, Jacob CBhat, Anusha G
Patlolla, Sri Harsha
Sinha, Shashank S
Miller, P Elliott
Lawler, Patrick R
van Diepen, Sean
Khanna, Ashish K
Zhao, David X
Vallabhajosyula, Saraschandra
Date
2022-02-04Journal
Critical Care ExplorationsPublisher
Wolters Kluwer HealthType
Article
Metadata
Show full item recordSee at
https://doi.org/10.1097/CCE.0000000000000637http://www.ncbi.nlm.nih.gov/pmc/articles/pmc8820909/
Abstract
Outcomes of interest included inhospital mortality, development of noncardiac organ failure, complications, utilization of guideline-directed procedures, length of stay, and hospitalization costs. Over 15 years, 444,253 AMI-CS admissions were identified, of which 27,057 (6%) included sepsis. The sepsis cohort had more comorbidities and had higher rates of noncardiac multiple organ failure (92% vs 69%) (all p < 0.001). In 2014, compared with 2000, the prevalence of sepsis increased from 0.5% versus 11.5% with an adjusted odds ratio (aOR) 11.71 (95% CI, 9.7-14.0) in ST-segment elevation myocardial infarction and 24.6 (CI, 16.4-36.7) (all p < 0.001) in non-ST segment elevation myocardial infarction. The sepsis cohort received fewer cardiac interventions (coronary angiography [65% vs 68%], percutaneous coronary intervention [43% vs 48%]) and had greater use of mechanical circulatory support (48% vs 45%) and noncardiac support (invasive mechanical ventilation [65% vs 41%] and acute hemodialysis [12% vs 3%]) (p < 0.001). The sepsis cohort had higher inhospital mortality (44.3% vs 38.1%; aOR, 1.21; 95% CI, 1.18-1.25; p < 0.001), longer length of stay (14.0 d [7-24 d] vs 7.0 d [3-12 d]), greater hospitalization costs (×1,000 U.S. dollars) ($176.0 [$85-$331] vs $77.0 [$36-$147]), fewer discharges to home (22% vs 44%) and more discharges to skilled nursing facilities (51% vs 28%) (all p < 0.001).Rights/Terms
Copyright © 2022 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Society of Critical Care Medicine.Identifier to cite or link to this item
http://hdl.handle.net/10713/17976ae974a485f413a2113503eed53cd6c53
10.1097/CCE.0000000000000637
Scopus Count
Collections
Related articles
- Impact of concomitant respiratory infections in the management and outcomes acute myocardial infarction-cardiogenic shock.
- Authors: Patlolla SH, Sundaragiri PR, Cheungpasitporn W, Doshi R, Vallabhajosyula S
- Issue date: 2021 Sep-Oct
- Influence of Body Mass Index on the Management and Outcomes of Acute Myocardial Infarction-Cardiogenic Shock in the United States, 2008-2017.
- Authors: Patlolla SH, Ponamgi SP, Sundaragiri PR, Cheungpasitporn W, Doshi RP, Alla VM, Nicholson WJ, Jaber WA, Vallabhajosyula S
- Issue date: 2022 Mar
- Acute Noncardiac Organ Failure in Acute Myocardial Infarction With Cardiogenic Shock.
- Authors: Vallabhajosyula S, Dunlay SM, Prasad A, Kashani K, Sakhuja A, Gersh BJ, Jaffe AS, Holmes DR Jr, Barsness GW
- Issue date: 2019 Apr 16
- Racial and ethnic disparities in the management and outcomes of cardiogenic shock complicating acute myocardial infarction.
- Authors: Patlolla SH, Shankar A, Sundaragiri PR, Cheungpasitporn W, Doshi RP, Vallabhajosyula S
- Issue date: 2022 Jan
- Pulmonary artery catheter use in acute myocardial infarction-cardiogenic shock.
- Authors: Vallabhajosyula S, Shankar A, Patlolla SH, Prasad A, Bell MR, Jentzer JC, Arora S, Vallabhajosyula S, Gersh BJ, Jaffe AS, Holmes DR Jr, Dunlay SM, Barsness GW
- Issue date: 2020 Jun